Cargando…

Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes

BACKGROUND: The Malay spoken in Brunei a South East Asian country where Malay is the national language is distinctive and different from Malay spoken in Malaysia, Singapore and Indonesia. This study aimed to develop a Brunei Malay version of the 5-level EQ-5D questionnaire (EQ-5D-5L) and to assess i...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, David, Abdullah, Awg Muhammad Khairulamin bin, Wang, Pei, Lin, Naing, Luo, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105939/
https://www.ncbi.nlm.nih.gov/pubmed/27835652
http://dx.doi.org/10.1371/journal.pone.0165555
_version_ 1782466966243508224
author Koh, David
Abdullah, Awg Muhammad Khairulamin bin
Wang, Pei
Lin, Naing
Luo, Nan
author_facet Koh, David
Abdullah, Awg Muhammad Khairulamin bin
Wang, Pei
Lin, Naing
Luo, Nan
author_sort Koh, David
collection PubMed
description BACKGROUND: The Malay spoken in Brunei a South East Asian country where Malay is the national language is distinctive and different from Malay spoken in Malaysia, Singapore and Indonesia. This study aimed to develop a Brunei Malay version of the 5-level EQ-5D questionnaire (EQ-5D-5L) and to assess its psychometric properties among patients with type 2 diabetes mellitus (T2DM). METHODS: The Brunei Malay EQ-5D-5L was developed by culturally adapting two existing Malay versions. A total of 154 Bruneians with T2DM completed the questionnaire in two different points of time with one week apart. Known-groups validity of the utility-based EQ-5D-5L index and visual analogue scale (EQ-VAS) was evaluated by comparing subgroups of patients known to differ in health status. Test-retest reliability was assessed using the intraclass correlation coefficient (ICC) or Cohen’s kappa. RESULTS: As hypothesized, patients known to have ‘better’ health had higher EQ-5D-5L index scores than those having ‘worse’ health in all 7 known-groups comparisons. The hypothesized difference in the EQ-VAS scores was observed in only 4 of the 7 known-groups comparisons. Kappa values ranged from 0.206 to 0.446 for the EQ-5D-5L items; the ICC value for the EQ-5D-5L index and EQ-VAS was 0.626 and 0.521, respectively. CONCLUSIONS: The utility-based EQ-5D-5L index appears to be valid and reliable for measuring the health of Brunei patients with T2DM. The validity of the EQ-VAS in Brunei requires further investigation.
format Online
Article
Text
id pubmed-5105939
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51059392016-12-08 Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes Koh, David Abdullah, Awg Muhammad Khairulamin bin Wang, Pei Lin, Naing Luo, Nan PLoS One Research Article BACKGROUND: The Malay spoken in Brunei a South East Asian country where Malay is the national language is distinctive and different from Malay spoken in Malaysia, Singapore and Indonesia. This study aimed to develop a Brunei Malay version of the 5-level EQ-5D questionnaire (EQ-5D-5L) and to assess its psychometric properties among patients with type 2 diabetes mellitus (T2DM). METHODS: The Brunei Malay EQ-5D-5L was developed by culturally adapting two existing Malay versions. A total of 154 Bruneians with T2DM completed the questionnaire in two different points of time with one week apart. Known-groups validity of the utility-based EQ-5D-5L index and visual analogue scale (EQ-VAS) was evaluated by comparing subgroups of patients known to differ in health status. Test-retest reliability was assessed using the intraclass correlation coefficient (ICC) or Cohen’s kappa. RESULTS: As hypothesized, patients known to have ‘better’ health had higher EQ-5D-5L index scores than those having ‘worse’ health in all 7 known-groups comparisons. The hypothesized difference in the EQ-VAS scores was observed in only 4 of the 7 known-groups comparisons. Kappa values ranged from 0.206 to 0.446 for the EQ-5D-5L items; the ICC value for the EQ-5D-5L index and EQ-VAS was 0.626 and 0.521, respectively. CONCLUSIONS: The utility-based EQ-5D-5L index appears to be valid and reliable for measuring the health of Brunei patients with T2DM. The validity of the EQ-VAS in Brunei requires further investigation. Public Library of Science 2016-11-11 /pmc/articles/PMC5105939/ /pubmed/27835652 http://dx.doi.org/10.1371/journal.pone.0165555 Text en © 2016 Koh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Koh, David
Abdullah, Awg Muhammad Khairulamin bin
Wang, Pei
Lin, Naing
Luo, Nan
Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title_full Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title_fullStr Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title_full_unstemmed Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title_short Validation of Brunei’s Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes
title_sort validation of brunei’s malay eq-5d questionnaire in patients with type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105939/
https://www.ncbi.nlm.nih.gov/pubmed/27835652
http://dx.doi.org/10.1371/journal.pone.0165555
work_keys_str_mv AT kohdavid validationofbruneismalayeq5dquestionnaireinpatientswithtype2diabetes
AT abdullahawgmuhammadkhairulaminbin validationofbruneismalayeq5dquestionnaireinpatientswithtype2diabetes
AT wangpei validationofbruneismalayeq5dquestionnaireinpatientswithtype2diabetes
AT linnaing validationofbruneismalayeq5dquestionnaireinpatientswithtype2diabetes
AT luonan validationofbruneismalayeq5dquestionnaireinpatientswithtype2diabetes